retatrutide triple agonist glp-1 gip glucagon phase 2 nejm 2023 Michael Weintraub, MD on X: "Retatrutide, a (GLP1, GIP, glucagon), just released trial results demonstrating 25% weight loss in half of people with #obesity. This amount of weight Retatrutide just posted the biggest
Pay in 4 interest-free payments of $7.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22




















